Salvatore M - Search Results

1

Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3.

Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S. Zannetti A, et al. Among authors: salvatore m. Clin Cancer Res. 2008 Aug 15;14(16):5209-19. doi: 10.1158/1078-0432.CCR-08-0374. Clin Cancer Res. 2008. PMID: 18698039 Free article.

2

Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.

Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M. Carriero MV, et al. Among authors: salvatore m. Cancer Res. 1994 Oct 15;54(20):5445-54. Cancer Res. 1994. PMID: 7923178

3

Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients.

Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M. Del Vecchio S, et al. Among authors: salvatore m. J Nucl Med. 1997 Sep;38(9):1348-51. J Nucl Med. 1997. PMID: 9293785 Free article.

4

Wash-out kinetics of 99mTc-MIBI and the scintigraphic determination of Pgp expression: reply.

Del Vecchio S, Ciarmiello A, Salvatore M. Del Vecchio S, et al. Among authors: salvatore m. Eur J Nucl Med. 1998 Feb;25(2):192. Eur J Nucl Med. 1998. PMID: 9537801 No abstract available.

5

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.

Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, Botti G, D'Aiuto G, Salvatore M. Ciarmiello A, et al. Among authors: salvatore m. J Clin Oncol. 1998 May;16(5):1677-83. doi: 10.1200/JCO.1998.16.5.1677. J Clin Oncol. 1998. PMID: 9586878 Clinical Trial.

6

Dynamic imaging: scintimammography.

Salvatore M, Del Vecchio S. Salvatore M, et al. Eur J Radiol. 1998 May;27 Suppl 2:S259-64. doi: 10.1016/s0720-048x(98)00072-2. Eur J Radiol. 1998. PMID: 9652532 Review.

7

Vitronectin binding to urokinase receptor in human breast cancer.

Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M. Carriero MV, et al. Among authors: salvatore m. Clin Cancer Res. 1997 Aug;3(8):1299-308. Clin Cancer Res. 1997. PMID: 9815812

8

Tc-99m sestamibi scintigraphy in multiple myeloma.

Di Gennaro F, Catalano L, Pace L, de Renzo A, Pinto AM, del Vecchio S, Rotoli B, Salvatore M. Di Gennaro F, et al. Among authors: salvatore m. Clin Nucl Med. 1999 Feb;24(2):115-6. doi: 10.1097/00003072-199902000-00009. Clin Nucl Med. 1999. PMID: 9988070

9

Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.

Catalano L, Pace L, Califano C, Pinto AM, De Renzo A, Di Gennaro F, Del Vecchio S, Fonti R, Salvatore M, Rotoli B. Catalano L, et al. Among authors: salvatore m. Haematologica. 1999 Feb;84(2):119-24. Haematologica. 1999. PMID: 10091409 Clinical Trial.

10

Clinical imaging of multidrug resistance in cancer.

Del Vecchio S, Ciarmiello A, Salvatore M. Del Vecchio S, et al. Among authors: salvatore m. Q J Nucl Med. 1999 Jun;43(2):125-31. Q J Nucl Med. 1999. PMID: 10429507 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,375 results

Search Page

Filters